{"id":220543,"date":"2026-08-27T10:25:16","date_gmt":"2026-08-27T04:55:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=220543"},"modified":"2026-08-27T10:25:16","modified_gmt":"2026-08-27T04:55:16","slug":"why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/","title":{"rendered":"Glaxosmithkline Pharmaceuticals Ltd. (GLAXO): Glaxosmithkline Pharmaceuticals Share Price hits fresh 52-week high"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO)<\/a> share price reached a fresh 52-week high of Rs 3,067.65 today and later stood at Rs 3,050, up 0.74% from the previous close. Market cap was Rs 50,483.85 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 27 August 2026 at 10:19 AM IST<\/p>\n<p style=\"margin-top:0!important;\">GLAXO Share Price is in focus after Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) moved to Rs 3,050 on 27 August 2026, up Rs 22.50 or 0.74% from the previous close of Rs 3,027.50. The stock also touched a fresh 52-week high of Rs 3,067.65 during the session, while market capitalisation stood at Rs 50,483.85 crore. The verified data confirms a new yearly high, but it does not establish a company-specific catalyst for the move.<\/p>\n<p>For readers tracking GLAXO Share Price Today, the session opened at Rs 3,027.50, matched the day\u2019s low of Rs 3,018.70 and reached the high of Rs 3,067.65 before settling at Rs 3,050. That places the stock very close to its fresh 52-week peak. In Univest coverage terms, this is the kind of event that typically draws searches for GLAXO Stock News, GLAXO Share Price News and GLAXO News Today, especially when a stock reaches a fresh yearly high without a disclosed trigger.<\/p>\n<p>On the numbers supplied, the event is relevant because it combines a fresh 52-week high with a large market capitalisation, elevated valuation metrics and strong profitability ratios. Univest is tracking the event as a factual price update rather than as a directional call. The key items to watch next are whether the price continues to hold near the recent high and how the valuation compares with the healthcare and pharmaceuticals peer set.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#GLAXO_Share_Price_Today_Price_Action_Analysis\" title=\"GLAXO Share Price Today: Price Action Analysis\">GLAXO Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Fundamental_Analysis\" title=\"Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Why_Investors_Are_Watching_GLAXO\" title=\"Why Investors Are Watching GLAXO\">Why Investors Are Watching GLAXO<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#About_Glaxosmithkline_Pharmaceuticals\" title=\"About Glaxosmithkline Pharmaceuticals\">About Glaxosmithkline Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Track_GLAXO_Share_Price_on_Univest\" title=\"Track GLAXO Share Price on Univest\">Track GLAXO Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#What_is_the_current_GLAXO_Share_Price\" title=\"What is the current GLAXO Share Price?\">What is the current GLAXO Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Did_GLAXO_hit_a_fresh_52-week_high_today\" title=\"Did GLAXO hit a fresh 52-week high today?\">Did GLAXO hit a fresh 52-week high today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#What_does_GLAXO_Share_Price_Today_show\" title=\"What does GLAXO Share Price Today show?\">What does GLAXO Share Price Today show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#How_is_GLAXO_valued_on_the_supplied_numbers\" title=\"How is GLAXO valued on the supplied numbers?\">How is GLAXO valued on the supplied numbers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#What_do_GLAXO_EPS_and_book_value_mean\" title=\"What do GLAXO EPS and book value mean?\">What do GLAXO EPS and book value mean?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#How_does_GLAXO_compare_with_pharmaceutical_peers\" title=\"How does GLAXO compare with pharmaceutical peers?\">How does GLAXO compare with pharmaceutical peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-glaxosmithkline-pharmaceuticals-ltd-share-price-52-week-high-2026-08-27\/#Where_can_I_track_GLAXO_Share_Price_on_Univest\" title=\"Where can I track GLAXO Share Price on Univest?\">Where can I track GLAXO Share Price on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"GLAXO_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>GLAXO Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,050<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,027.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 22.5 (+0.74%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,027.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,067.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 3,018.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.47 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 50,483.85 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) traded at Rs 3,050 versus the previous close of Rs 3,027.5, a rise of 0.74%. The stock opened at Rs 3,027.5, reached a high of Rs 3,067.65 and touched a low of Rs 3,018.7.<\/p>\n<p>GLAXO Share Price Today shows a narrow intraday range around the upper end of the session. The stock opened at Rs 3,027.50, traded between Rs 3,018.70 and Rs 3,067.65, and closed at Rs 3,050. Compared with the previous close of Rs 3,027.50, the gain was Rs 22.50, or 0.74%. The fresh 52-week high of Rs 3,067.65 is only slightly above the closing price, which means the market has already marked a new yearly high and then eased modestly from the day\u2019s top.<\/p>\n<p>Turnover for the session was Rs 0.47 crore. That is a factual traded-value measure for the day and can be read alongside the price move, not as a conclusion about participation or sentiment. For GLAXO Share Price, the important point is that the stock set a new one-year high and stayed near that level through the close. In share-market language, that is exactly why GLAXO Stock News is being searched today: the price event is clear, and the market data are fresh.<\/p>\n<p>From a daily price perspective, the move was positive, measured and tightly contained. There is no need to stretch the data beyond what it shows. The stock finished above its prior close and at a level that confirms a fresh 52-week high. For Univest readers following GLAXO Share Price Live and GLAXO Share Price Update, the session was notable because the day\u2019s top and the 52-week high were the same at Rs 3,067.65.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Fundamental_Analysis\"><\/span><strong>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 50,483.85 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">66.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 63.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 148.77<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.88%<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) fundamental metrics show P\/E 48.02x, P\/B 20.35x, ROE 48.76%, ROCE 66.79%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. has a market capitalisation of Rs 50483.85 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 48.02x, P\/B at 20.35x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 48.76% and ROCE of 66.79%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 63.05, book value per share of Rs 148.77, dividend yield of 1.88%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 30.54x, median ROE of 11.83%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.02x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.54x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">47.16x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.19x to 671.51x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.35x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.76x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">48.76%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.83%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">66.79%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.75%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 50,483.85 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 623.8 crore<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P\/E ratio of 48.02x, which is above the benchmark median of 30.54x, a difference of +57.24%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROE of 48.76%, which is above the benchmark median of 11.83%, a difference of +312.17%. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a ROCE of 66.79%, which is above the benchmark median of 13.75%, a difference of +385.75%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/anthem\/anthem-biosciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Anthem Biosciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ANTHEM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">49,292.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">90.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.63<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.98<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">29.62<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ipcalab\/ipca-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ipca Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">IPCALAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">48,969.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">37.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.84<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.41<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/gland\/gland-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Gland Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">GLAND<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46,538.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">42.46<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.96<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/abbotindia\/abbott-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Abbott India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ABBOTINDIA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">56,173.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">46.72<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/ajantpharm\/ajanta-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ajanta Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AJANTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44,449.8<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">39.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.12<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">25.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.67<\/td>\n<\/tr>\n<\/table>\n<p>Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a P\/E ratio of 48.02x compared with the displayed peer median of 39.03x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.76% compares with a peer median of 21.98% across the companies shown in the table. ROCE stood at 66.79% versus the displayed peer median of 29.62%, providing a capital-efficiency comparison. Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) has a market capitalisation of Rs 50,483.85 crore. Among the 5 peers shown, 1 has a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_GLAXO\"><\/span><strong>Why Investors Are Watching GLAXO<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>GLAXO Share Price closed at Rs 3,050 after touching a fresh 52-week high of Rs 3,067.65.<\/li>\n<li>The day\u2019s move was Rs 22.50, or 0.74%, versus the previous close of Rs 3,027.50.<\/li>\n<li>Market capitalisation stood at Rs 50,483.85 crore in the latest snapshot.<\/li>\n<li>P\/E was 48.02, P\/B was 20.35, ROE was 48.76 and ROCE was 66.79.<\/li>\n<li>Within the supplied peer set, GLAXO\u2019s ROE and ROCE were above the listed comparables.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Glaxosmithkline_Pharmaceuticals\"><\/span><strong>About Glaxosmithkline Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glaxosmithkline Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied company profile confirms the listing identity used for GLAXO Share Price coverage on Univest. This article uses only the verified market and financial fields provided in the data feed, with the company\u2019s classification and key ratios forming the core of the analysis.<\/p>\n<p>For readers following GLAXO Company News, the main factual reference points are the current share price, the fresh 52-week high, market capitalisation, EPS, book value and return ratios. Those elements are enough to place GLAXO Share Price within the broader pharmaceutical context without adding unsupported business detail.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_GLAXO_Share_Price_on_Univest\"><\/span><strong>Track GLAXO Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/glaxo\/glaxosmithkline-pharmaceuticals-ltd-share-price-today\">Glaxosmithkline Pharmaceuticals Ltd. (GLAXO) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Track GLAXO Share Price on Univest for live price updates, 52-week levels, valuation ratios, shareholding pattern, sector context and market insights. Univest also helps readers revisit GLAXO Share Price Today, GLAXO Stock News and GLAXO Share Price Update in one place as new market data arrive.<\/p>\n<p>For users comparing GLAXO Share News with other healthcare names, Univest brings together the same factual fields used in this article so that the stock can be followed alongside peer comparison and company fundamentals.<\/p>\n<p><strong>In conclusion, GLAXO Share Price has reached a fresh 52-week high, and the current data show a strong profitability profile alongside a relatively rich valuation. Univest will continue to track GLAXO Stock News, GLAXO Share Price Today and the next price update as the market forms a new reference point around Rs 3,067.65.<\/strong><\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_current_GLAXO_Share_Price\"><\/span><strong>What is the current GLAXO Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO Share Price is Rs 3,050. The stock closed Rs 22.50, or 0.74%, above the previous close of Rs 3,027.50 after touching a fresh 52-week high of Rs 3,067.65 in the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_GLAXO_hit_a_fresh_52-week_high_today\"><\/span><strong>Did GLAXO hit a fresh 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. GLAXO touched Rs 3,067.65, which is the fresh 52-week high in the supplied data. The closing price was slightly lower at Rs 3,050, but the yearly high was set during the day.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_GLAXO_Share_Price_Today_show\"><\/span><strong>What does GLAXO Share Price Today show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO Share Price Today shows a small gain from the previous close, a new yearly high and a close near the day\u2019s top. The session opened at Rs 3,027.50 and traded within a narrow range.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_GLAXO_valued_on_the_supplied_numbers\"><\/span><strong>How is GLAXO valued on the supplied numbers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO has a P\/E of 48.02 and a P\/B of 20.35. Both are above the industry medians in the supplied benchmark set, while ROE and ROCE are also well above the same comparison group.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_GLAXO_EPS_and_book_value_mean\"><\/span><strong>What do GLAXO EPS and book value mean?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GLAXO EPS is Rs 63.05 and book value per share is Rs 148.77. EPS shows earnings attributable to each share, while book value reflects accounting net worth per share at the latest reported point.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_GLAXO_compare_with_pharmaceutical_peers\"><\/span><strong>How does GLAXO compare with pharmaceutical peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> In the supplied peer list, GLAXO\u2019s ROE of 48.76 and ROCE of 66.79 are above the listed comparables. Its market capitalisation is also larger than several peers in the comparison set.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_track_GLAXO_Share_Price_on_Univest\"><\/span><strong>Where can I track GLAXO Share Price on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Univest tracks GLAXO Share Price with live updates, 52-week levels, valuation ratios, shareholding pattern and sector context. Readers can use the platform to revisit the same verified market data as new snapshots appear.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glaxosmithkline Pharmaceuticals Ltd. Share Price hits a new 52-week high at Rs 3,050. marking a 0.74% rise today. Market cap stands at Rs 50,483.85 crore.<\/p>\n","protected":false},"author":29,"featured_media":220542,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-220543","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["220542"],"rank_math_title":["GLAXO Share Price hits fresh 52-week high: analysis"],"rank_math_description":["GLAXO Share Price hits a fresh 52-week high at Rs 3,050. Read price action, valuation, sector benchmarks and peer context."],"rank_math_focus_keyword":["GLAXO Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Glaxosmithkline_Pharmaceuticals_Ltd_GLAXO_Glaxosmithkline_Pharmaceuticals_Share_Price_hits_fresh_52_week_high_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/220543","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=220543"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/220543\/revisions"}],"predecessor-version":[{"id":220544,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/220543\/revisions\/220544"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/220542"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=220543"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=220543"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=220543"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}